FDA Approval Activities for this Drug
Requip (ropinirole hydrochloride) Tablets, GlaxoSmithKline NDA 20-658 / S012 | REQUIP (ropinirole hydrochloride) Tablets, SmithKline Beecham, New or Modified Indication | Ropinirole Hydrochloride Tablets, Roxane Labs, Tentative Approval